Agios Pharmaceuticals Inc
NASDAQ:AGIO

Watchlist Manager
Agios Pharmaceuticals Inc Logo
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Watchlist
Price: 26.85 USD -1.54% Market Closed
Market Cap: 1.6B USD

Relative Value

The Relative Value of one AGIO stock under the Base Case scenario is 32.42 USD. Compared to the current market price of 26.85 USD, Agios Pharmaceuticals Inc is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AGIO Relative Value
Base Case
32.42 USD
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
20
Median 3Y
65
Median 5Y
53.9
Industry
7.9
Forward
33.3
vs History
vs Industry
12
Median 3Y
-5.1
Median 5Y
-4
Industry
23.7
Forward
-3.7
vs History
vs Industry
Median 3Y
-5
Median 5Y
-5
Industry
22
vs History
vs Industry
Median 3Y
-5
Median 5Y
-5
Industry
23.8
vs History
85
vs Industry
57
Median 3Y
1.5
Median 5Y
1.5
Industry
3.3
vs History
71
vs Industry
24
Median 3Y
35
Median 5Y
29.4
Industry
8.3
Forward
13
vs History
71
vs Industry
21
Median 3Y
39.3
Median 5Y
33.2
Industry
10.1
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.2
Industry
6.4
Forward
-1.3
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.2
Industry
7
Forward
-1.3
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.7
Industry
8.3
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-2.7
Industry
6.5
vs History
77
vs Industry
55
Median 3Y
2
Median 5Y
2.1
Industry
5.7

Multiples Across Competitors

AGIO Competitors Multiples
Agios Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Agios Pharmaceuticals Inc
NASDAQ:AGIO
1.6B USD 34.9 -3.9 -1.3 -1.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 738 486.8 -160 354 -194 720.9 -192 498.9
US
Abbvie Inc
NYSE:ABBV
401.5B USD 6.7 171 16.5 23.5
US
Amgen Inc
NASDAQ:AMGN
173.9B USD 4.8 24.8 18 18
US
Gilead Sciences Inc
NASDAQ:GILD
149.8B USD 5.2 18.5 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.5B USD 9.8 31.2 22.8 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 088.1 -532.8 -580.2 -564.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.6B USD 5.6 17.4 16.6 18.8
AU
CSL Ltd
ASX:CSL
86.8B AUD 3.7 19.2 12.9 16.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.9B USD 16.2 1 192 156.5 189.8
NL
argenx SE
XBRU:ARGX
44.1B EUR 14.4 33.9 58.4 60
P/E Multiple
Earnings Growth PEG
US
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Average P/E: 188.5
Negative Multiple: -3.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 354 N/A N/A
US
Abbvie Inc
NYSE:ABBV
171
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.5
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
9%
1.9
AU
CSL Ltd
ASX:CSL
19.2
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 192
N/A N/A
NL
argenx SE
XBRU:ARGX
33.9
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Average EV/EBITDA: 39.3
Negative Multiple: -1.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 720.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.8
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
11%
1.5
AU
CSL Ltd
ASX:CSL
12.9
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
156.5
N/A N/A
NL
argenx SE
XBRU:ARGX
58.4
839%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Average EV/EBIT: 45.3
Negative Multiple: -1.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 498.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.5
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
13%
1.4
AU
CSL Ltd
ASX:CSL
16.1
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
189.8
N/A N/A
NL
argenx SE
XBRU:ARGX
60
N/A N/A